Literature DB >> 32380534

Poor tolerability to ponatinib in Indian CML patients.

Charanpreet Singh1, Arihant Jain1, Deepesh Lad1, Gaurav Prakash1, Alka Khadwal1, Dinesh Bhurani2, Rayaz Ahmed2, Narendra Agrawal2, Jose Easow3, Neelam Varma4, Pankaj Malhotra1.   

Abstract

Entities:  

Year:  2020        PMID: 32380534      PMCID: PMC7218412          DOI: 10.1182/bloodadvances.2020001944

Source DB:  PubMed          Journal:  Blood Adv        ISSN: 2473-9529


× No keyword cloud information.
  4 in total

1.  Ponatinib-induced lamellar ichthyosis-like eruption.

Authors:  Vishal Thakur; Pankaj Malhotra; Deepesh Lad; Debajyoti Chatterjee; Keshavamurthy Vinay; Sunil Dogra
Journal:  Int J Dermatol       Date:  2020-03-20       Impact factor: 2.736

2.  Ponatinib efficacy and safety in Philadelphia chromosome-positive leukemia: final 5-year results of the phase 2 PACE trial.

Authors:  Jorge E Cortes; Dong-Wook Kim; Javier Pinilla-Ibarz; Philipp D le Coutre; Ronald Paquette; Charles Chuah; Franck E Nicolini; Jane F Apperley; H Jean Khoury; Moshe Talpaz; Daniel J DeAngelo; Elisabetta Abruzzese; Delphine Rea; Michele Baccarani; Martin C Müller; Carlo Gambacorti-Passerini; Stephanie Lustgarten; Victor M Rivera; Frank G Haluska; François Guilhot; Michael W Deininger; Andreas Hochhaus; Timothy P Hughes; Neil P Shah; Hagop M Kantarjian
Journal:  Blood       Date:  2018-03-22       Impact factor: 22.113

3.  Side-effects profile and outcomes of ponatinib in the treatment of chronic myeloid leukemia.

Authors:  Onyee Chan; Chetasi Talati; Leidy Isenalumhe; Samantha Shams; Lisa Nodzon; Michael Fradley; Kendra Sweet; Javier Pinilla-Ibarz
Journal:  Blood Adv       Date:  2020-02-11

4.  Asciminib in Chronic Myeloid Leukemia after ABL Kinase Inhibitor Failure.

Authors:  Timothy P Hughes; Michael J Mauro; Jorge E Cortes; Hironobu Minami; Delphine Rea; Daniel J DeAngelo; Massimo Breccia; Yeow-Tee Goh; Moshe Talpaz; Andreas Hochhaus; Philipp le Coutre; Oliver Ottmann; Michael C Heinrich; Juan L Steegmann; Michael W N Deininger; Jeroen J W M Janssen; Francois-Xavier Mahon; Yosuke Minami; David Yeung; David M Ross; Martin S Tallman; Jae H Park; Brian J Druker; David Hynds; Yuyan Duan; Christophe Meille; Florence Hourcade-Potelleret; K Gary Vanasse; Fabian Lang; Dong-Wook Kim
Journal:  N Engl J Med       Date:  2019-12-12       Impact factor: 91.245

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.